Related Experiment Video
Updated: Aug 29, 2026
Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
Published on: February 12, 2022
[Combined preoperative xeloda and radiotherapy for lower rectal cancer]
Chao-ping Zhuang1, Ting-han Li, Jun-wei Wu
1Department of General Surgery, Second Hospital of Shantou Medical College, Shantou University, Guangdong 515041, China.
Objective:
To evaluate the effect of combined preoperative xeloda and pelvic radiotherapy on locally advanced lower rectal cancer.
Methods:
Sixty lower rectal cancer patients were divided randomly into two groups. 30 patients (Group A) were treated with operation alone and 30 patients (Group B) were treated with xeloda and radiotherapy before operation.
Results:
The operative resection, anal preservation and local recurrence rates were 86.66%, 33.33%, 15.38% in group A and 100%, 83.33%, 0% in group B (P < 0.05 and P < 0.01).
Conclusion:
Combined preoperative xeloda and radiotherapy for lower rectal cancer is able to significantly improve the operative resection, anal preservation and decrease the local recurrence rates.
